UNITED THERAPEUTICS Corp (UTHR)
As of Sep 20, 2026, UNITED THERAPEUTICS Corp (UTHR) scores 4.8/10 on AlphaStocks' five-model composite, #121 of 168 Health Care stocks.
Health Care / Biotechnology
S&P MidCap 400$494.96
Below average on several measures. Research carefully.
Weak
Score based on 5 of 5 models — high confidence
Data as of Sep 20, 2026
Is UNITED THERAPEUTICS Corp a Good Investment in 2026?
UNITED THERAPEUTICS Corp (UTHR) scores 4.8 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates UNITED THERAPEUTICS Corp as Strong (7/9). The Graham model is the least favorable, rating it Neutral. UNITED THERAPEUTICS Corp ranks #121 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Trades at 18x earnings — near sector median of 30x.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Attractive
Business quality & competitive moat
Graham
Neutral
64% above fair value
Lynch
Strong
PEG 0.6 · Fast Grower
Greenblatt
Attractive
Earnings yield 6.1% · ROC 31%
Frequently Asked Questions
Is UNITED THERAPEUTICS Corp (UTHR) a good investment?
What is UNITED THERAPEUTICS Corp's Piotroski F-Score?
Is UTHR overvalued or undervalued?
How does UTHR compare to other Health Care stocks?
What do investment models say about UTHR?
Similar Stocks
Compare UTHR with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer